Oramed Pharmaceuticals Inc (ORMP) support and resistance · rev $1.3M
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
This page maps Oramed Pharmaceuticals Inc (ORMP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
ORMP currently screens at market cap $87.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ORMP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ORMP quote page for the session range and the stock page for the full model.
Not investment advice.